Skip to main content
M
Doctor-Reviewed Content Verified Hospital Data Updated Medical Information Patient-First Guidance Not for Emergencies — Call 911

Penile Reconstruction (Phalloplasty) — Surgical Techniques & Outcomes — Cost, Top Hospitals & Success Rates | MyMedicPlus

Updated: 2026-07-07
Ad — after-intro

Quick Facts

Procedure Type
Reconstructive / Gender-Affirming Surgery
Gold Standard Technique
Radial Forearm Free Flap (RFF) Phalloplasty
Anaesthesia
General anaesthesia, 8–14 hours
Hospital Stay
7–14 days
Full Recovery Timeline
12–24 months across all stages
Urethral Success Rate
70–85% single-stage (RFF)
Prosthesis Stage
12–18 months after phalloplasty
Reviewed By
MyMedicPlus Medical Review Board

Overview: What Is Penile Reconstruction?

Penile reconstruction — also called phalloplasty — is a complex group of surgical procedures designed to create or restore a functional and aesthetically appropriate penis. It is performed in three broad clinical contexts: gender-affirming surgery for transgender men and non-binary individuals; total penile reconstruction following penile loss due to cancer, trauma, or infection; and correction of severe congenital anomalies such as micropenis or bladder exstrophy-epispadias complex.

The goals of surgery are multifaceted: to create a neophallus of appropriate length and girth, to allow voiding while standing, to preserve tactile and erogenous sensation, to enable sexual intercourse after penile prosthesis implantation, and to achieve a cosmetically acceptable result with a concealed donor-site scar. Achieving all five goals simultaneously in a single stage remains one of the most technically demanding feats in reconstructive urology and plastic surgery.

Surgery is carried out by a multidisciplinary team including a plastic and reconstructive surgeon, a urologist, specialist nursing staff, physiotherapists, and — in gender-affirming cases — mental health professionals and an endocrinologist. Pre-operative planning involves detailed vascular imaging of the donor site, urodynamic studies, and psychological preparation. Patients undergoing gender-affirming phalloplasty are typically required to complete a minimum of 12 months of continuous hormone therapy consistent with WPATH Standards of Care v8 (2022).

  • RFF phalloplasty: Gold standard for simultaneous urethral incorporation and reliable innervation.
  • ALT phalloplasty: Preferred when forearm donor-site cosmesis is a priority.
  • Metoidioplasty: Single-stage procedure using the hormonally enlarged clitoris; lower complication rate.
  • Staged approaches: Many surgeons divide phalloplasty into 2–4 stages for safety and optimal outcomes.

Outcomes have improved substantially with the centralisation of cases in high-volume centres. Centres performing more than 30 phalloplasties annually report significantly lower urethral complication rates and flap failure rates than lower-volume providers.

Conditions and Indications for Penile Reconstruction

Penile reconstruction addresses a range of medical and surgical indications grouped into three main categories:

1. Gender Dysphoria / Gender Incongruence
This is currently the most common indication for phalloplasty in high-income countries. Transgender men and some non-binary individuals seek phalloplasty as part of gender-affirming genital surgery (also called "lower surgery"). Prior vaginectomy, hysterectomy, and/or oophorectomy is often but not universally completed before phalloplasty referral. WPATH SOC8 provides criteria and a referral pathway.

2. Penile Loss Following Disease or Injury
Total or subtotal penectomy is performed for penile squamous cell carcinoma, Fournier's gangrene (necrotising fasciitis of the perineum), or severe perineal trauma such as blast injuries or high-voltage electrical burns. In these patients, reconstruction restores urinary function, enables sexual activity, and addresses the profound psychological impact of penile loss.

3. Congenital and Developmental Conditions
Severe hypospadias with chordee, epispadias, bladder exstrophy-epispadias complex, micropenis unresponsive to hormonal therapy, and ambiguous genitalia may all require phalloplasty as part of a staged reconstructive programme. These cases are often managed by specialist paediatric urologists initially, with adult reconstruction deferred until physical and psychological maturity.

  • Penile cancer (post-total penectomy reconstruction)
  • Fournier's gangrene with extensive penile loss
  • Traumatic amputation (motor vehicle accidents, industrial injuries)
  • Gender dysphoria meeting WPATH SOC8 eligibility criteria
  • Severe hypospadias or epispadias failing prior repair
  • Bladder exstrophy-epispadias complex
  • Micropenis (<2 cm stretched penile length in adults unresponsive to androgens)

Careful multidisciplinary assessment, realistic expectation-setting, and psychological support are essential in all categories before proceeding to major reconstructive surgery.

Eligibility and Patient Selection Criteria

Appropriate patient selection is fundamental to achieving the best outcomes from penile reconstruction. Eligibility criteria vary by indication but share several common requirements.

General Medical Fitness: Patients must be fit for prolonged general anaesthesia, typically 8–14 hours for single-stage RFF phalloplasty. Cardiorespiratory assessment, optimisation of diabetes or hypertension, and smoking cessation for at least 6–8 weeks are standard prerequisites. Active tobacco use is an absolute contraindication in many centres due to its direct adverse effect on microvascular anastomosis patency and wound healing. BMI below 35 kg/m² is typically required.

Vascular Anatomy Assessment: The radial forearm free flap requires adequate ulnar artery circulation to perfuse the hand after radial artery sacrifice. An Allen's test and, where equivocal, Doppler ultrasound or CT angiography of the forearm must confirm ulnar dominance before RFF harvest is planned.

Gender-Affirming Surgery Criteria (WPATH SOC8, 2022):

  • Persistent, well-documented gender incongruence
  • Capacity to provide fully informed consent
  • Age of majority in the patient's country (or parental consent in adolescents after multidisciplinary assessment)
  • At least 12 months of gender-affirming hormone therapy (unless medically contraindicated)
  • Assessment by at least one qualified mental health professional

Post-Cancer Reconstruction: Oncological clearance with confirmed negative margins and no evidence of active metastatic disease is required. A minimum 6–12 month disease-free interval is recommended for aggressive tumours to reduce the risk of reconstruction in the context of occult residual disease.

Psychological Readiness: All candidates benefit from pre-operative psychological support regardless of indication. Patients must have a realistic understanding of the staged nature of surgery, the expected complication profile (particularly urethral fistula and stricture), and the 12–24 month timeline to full functional outcomes including prosthesis implantation.

Surgical Techniques and Treatment Options

Penile reconstruction encompasses several distinct surgical techniques selected based on patient anatomy, goals, donor-site preferences, and surgeon expertise.

Radial Forearm Free Flap (RFF) Phalloplasty — Gold Standard
The RFF flap harvests a thin, pliable skin paddle (approximately 14×15 cm) from the non-dominant forearm, incorporating the radial artery, cephalic vein, and branches of the medial and lateral antebrachial cutaneous nerves. The flap is tubed upon itself using the tube-within-a-tube technique to form the neourethra and outer phallus simultaneously. Microsurgical anastomosis is performed to recipient vessels (usually the inferior epigastric or femoral system). The technique achieves reliable protective and erogenous sensation and allows incorporation of the neourethra in a single surgical stage in experienced hands.

Anterolateral Thigh (ALT) Flap Phalloplasty
The ALT flap provides a larger, bulkier skin paddle with a more concealed donor site. It can be raised as a pedicled or free flap. The thicker subcutaneous tissue may limit single-stage urethral incorporation, and sensation transfer is more variable than with RFF. ALT is preferred when forearm donor-site cosmesis is a patient priority.

Metoidioplasty
This technique releases and advances the hormonally hypertrophied clitoris (typically 4–6 cm after testosterone therapy) to create a small but fully sensate neophallus. Urethral lengthening is performed using buccal mucosa grafts and local flaps. It enables standing urination but does not permit penetrative intercourse. Recovery is substantially shorter than phalloplasty, with a lower overall complication rate.

Glansplasty
Reconstruction of the glans penis using a composite graft or local skin rearrangement improves the cosmetic appearance of the neophallus tip and may enhance erogenous sensitivity.

Urethral Lengthening
Extension of the urethra to the neophallus tip is performed using the flap skin ("tube-in-tube" in RFF), buccal mucosa grafts, or a combination. This is the most complication-prone component, with urethral fistula rates of 15–40% and stricture rates of 10–25% depending on technique and centre volume.

Inflatable Penile Prosthesis Implantation
An inflatable penile prosthesis (most commonly the AMS 700 series) is implanted into the neophallus 12–18 months after phalloplasty, once the neophallus has a stable blood supply and sensation is partially recovered. Implant survival at 5 years approaches 70–80% in experienced centres, lower than in native penis implantation due to altered neophallus vascularity.

Benefits and Expected Functional Outcomes

When performed in high-volume specialist centres, penile reconstruction delivers substantial functional, psychological, and social benefits well-documented in the peer-reviewed literature.

Functional Benefits:

  • Voiding while standing: Achieved in 85–90% of patients with successful urethral lengthening, eliminating a major source of social dysphoria and restoring dignified urinary function in post-cancer patients.
  • Tactile and protective sensation: The RFF flap achieves meaningful tactile sensation in approximately 90% of patients within 12–18 months, protecting the neophallus from unrecognised injury. Sensation continues to improve for up to 2 years post-operatively.
  • Erogenous sensation and orgasm: Preserved clitoral sensitivity (in transgender men via the clitoral remnant or buried clitoris technique) or reconnected dorsal penile nerve (in post-cancer cases) enables orgasm in the majority of patients. Over 80% of patients with preserved clitoral sensation report the ability to achieve orgasm post-phalloplasty.
  • Sexual intercourse with prosthesis: Patient satisfaction with sexual function after penile prosthesis implantation approaches 75–85% in long-term series, with partners also reporting high satisfaction rates.

Psychological and Quality-of-Life Benefits:
Multiple studies using validated instruments including the WHOQOL-BREF and GHQ-12 document significant improvements in body image, gender congruence, and overall quality of life following gender-affirming phalloplasty. Post-operative regret rates are consistently below 2% in contemporary cohorts — among the lowest of any elective surgical procedure in medicine.

Aesthetic Outcomes:
Patient-reported satisfaction with phallus appearance ranges from 70–90% across techniques, with the highest scores in RFF cohorts augmented by glansplasty. Donor-site appearance is rated satisfactory by 75–80% of RFF patients, with full-thickness skin grafting and primary closure minimising forearm contracture.

Risks, Complications, and Known Limitations

Penile reconstruction is major surgery with a substantial and well-documented complication profile. Full informed consent requires thorough pre-operative counselling covering all likely and serious adverse events.

Urethral Complications (Most Frequent):
Urethral fistula — an abnormal opening allowing urine to escape through the skin proximal to the meatus — occurs in 15–40% of phalloplasty cases. The majority close spontaneously with prolonged urethral catheterisation; persistent fistulae require secondary surgical repair, typically delayed 6–12 months. Urethral stricture occurs in 10–25%, usually at the anastomotic junction between the fixed native urethra and the neourethra, and is treated by optical urethrotomy, progressive dilation, or open urethroplasty with buccal mucosa grafting.

Flap Complications:

  • Partial or total flap loss: Occurs in 1–5% of cases in experienced centres due to arterial or venous thrombosis at the microvascular anastomosis. Total flap loss is devastating and requires secondary reconstruction.
  • Wound dehiscence: Perineal wound breakdown occurs in 10–20%, with significantly higher rates in patients who have received prior pelvic radiotherapy.
  • Haematoma and seroma: Managed by surgical or image-guided drainage; rarely threaten flap viability if treated promptly.

Penile Prosthesis Complications:
Implant erosion through neophallus skin, infection, and mechanical failure affect 20–30% of prostheses over 5 years — substantially higher than in native penile implantation. Revision surgery or prosthesis removal may be required.

Donor-Site Morbidity:
RFF harvest leaves a visible forearm scar requiring split-thickness skin grafting and may cause reduced grip strength in approximately 5% of cases. Radial nerve sensory branch injury produces temporary dorsal hand paraesthesia in 10–15%.

General Anaesthetic and Thromboembolic Risks:
Operative duration of 8–14 hours significantly elevates thromboembolic risk. Routine pharmacological and mechanical DVT prophylaxis is mandatory. Pulmonary embolism, surgical site infection, and delayed wound healing are additional systemic risks.

Follow-Up, Recovery, and Staged Surgical Progression

Recovery from penile reconstruction is a carefully staged process extending over 12–24 months. Understanding the timeline helps patients plan personal, professional, and financial arrangements appropriately.

Immediate Post-Operative Period (Days 0–7 in hospital):
The neophallus is monitored hourly for signs of vascular compromise using clinical assessment (colour, temperature, Doppler signal) and, in some centres, implantable Doppler probes or near-infrared spectroscopy. A urethral catheter and suprapubic catheter are maintained for 3–4 weeks to protect the neourethra during healing. Low-molecular-weight heparin DVT prophylaxis commences within 24 hours of surgery. Patients typically remain hospitalised for 7–14 days.

Early Recovery (Weeks 1–6):
Patients are discharged with catheter care instructions and perineal wound dressings. Occupational therapy assessment for forearm function begins at 2 weeks in RFF patients. Patients are advised to avoid heavy lifting, prolonged sitting, tight clothing, and sexual activity. A surgical review appointment is typically scheduled at 2 weeks.

Intermediate Recovery (Months 2–6):
Catheter removal occurs at 3–4 weeks, followed by a formal voiding trial. Urethral complications (fistula, stricture) are most commonly identified during this phase. Neophallus sensation begins returning from month 3, continuing to improve for up to 2 years. Residual swelling and induration resolve over 3–6 months.

Penile Prosthesis Stage (Months 12–18):
Once the neophallus has stable vascularity, partial sensation recovery, and all urethral complications have been addressed, inflatable penile prosthesis implantation is planned. Pre-operative imaging confirms adequate neophallus dimensions. The prosthesis is typically activated 6 weeks post-implantation.

  • Scheduled urology reviews at 3, 6, 12, and 24 months
  • Physiotherapy for donor-site rehabilitation (hand/forearm or thigh)
  • Psychological support and peer support group access throughout all stages
  • Urine flow rate studies and urethroscopy if obstruction or incomplete voiding is suspected

Cost, Insurance Coverage, and Financial Considerations

Penile reconstruction is among the most expensive elective surgical procedures, reflecting its technical complexity, prolonged operating time, specialist team requirements, multi-stage nature, and high rates of revisional surgery.

Estimated Global Costs (USD, 2025–2026):

  • United States: USD 50,000–150,000 per stage depending on institution, geographic location, and insurance coverage. Gender-affirming phalloplasty is increasingly covered under the Affordable Care Act and expanding state Medicaid programmes.
  • United Kingdom (private): GBP 40,000–100,000. NHS funding is available for gender-affirming phalloplasty through Gender Identity Clinics, though waiting times commonly exceed 3–5 years from referral to surgery.
  • India: INR 4,00,000–15,00,000 (approximately USD 4,800–18,000), making India one of the most accessible destinations for medical tourism patients seeking phalloplasty at accredited centres in Mumbai, Delhi, and Hyderabad.
  • Thailand: USD 20,000–60,000 — Thailand maintains a globally recognised specialisation in gender-affirming genital surgery with experienced multi-disciplinary programmes.

Key Cost-Driving Factors:

  • Number of planned surgical stages (1 vs 2–4)
  • Flap technique selected (RFF vs ALT vs pedicled)
  • Inclusion of urethral lengthening and glansplasty
  • Penile prosthesis implantation (a separate surgical stage adding 25–40% to total programme cost)
  • High-volume specialist centre vs general plastic surgery unit
  • Need for revisional surgery for urethral complications or flap-related issues
  • Post-operative physiotherapy, psychological support, and outpatient review costs

Patients travelling internationally must ensure the selected centre has a dedicated gender surgery or reconstructive urology programme, verifiable outcomes data, and comprehensive arrangements for post-operative follow-up in the patient's home country before departure.

Alternatives and Non-Surgical Options

Not all patients with penile loss or gender dysphoria choose phalloplasty. Several alternatives address specific functional or psychological needs with different risk-benefit profiles.

Metoidioplasty (Surgical Alternative):
For transgender men who desire a standing void and erogenous sensation but do not require a phallus capable of penetrative intercourse, metoidioplasty is a compelling alternative. Operative time is 2–4 hours (vs 8–14 hours for phalloplasty), hospital stay is shorter, recovery is faster, and the overall complication rate is substantially lower. Patient satisfaction rates with metoidioplasty are comparable to phalloplasty among patients with realistic expectations about phallus size. Many patients choose metoidioplasty initially and progress to phalloplasty later.

Prosthetic External Devices:
Stand-to-pee (STP) devices and packing prostheses allow some transgender men to fulfil gender-expression needs without surgery. These are fully reversible, low-cost alternatives suitable for patients who are medically ineligible, are not ready for surgery, or have personal or cultural reasons to defer operative intervention.

Penile Allotransplantation (Experimental):
Total penile transplantation from a deceased donor has been performed successfully in fewer than 15 cases worldwide, with the first reported in South Africa in 2015. Long-term immunosuppression requirements (analogous to other composite tissue allografts such as hand transplants) and significant ethical challenges limit wider application. It remains experimental and is available only in a small number of specialist research centres.

Urethral Reconstruction Without Phalloplasty:
In patients requiring primarily restored voiding function without full phalloplasty, staged urethroplasty using buccal mucosa substitution grafts can achieve satisfactory urinary outcomes with substantially lower surgical risk.

Non-Surgical Gender-Affirming Care:
For some patients with gender dysphoria, non-surgical affirming care — including social transition, hormone therapy, voice training, chest (top) surgery, and ongoing psychological support — may be sufficient to achieve acceptable quality of life without genital surgery. The decision must be fully patient-led in collaboration with an experienced gender health multidisciplinary team, with no pressure to proceed to any specific surgical intervention.

Frequently Asked Questions

Phalloplasty uses a skin flap from the forearm (RFF) or thigh (ALT) to create a full-sized neophallus capable of penetrative intercourse after prosthesis implantation. Metoidioplasty releases and advances the clitoris (enlarged by testosterone therapy) to form a smaller but fully sensate phallus that enables standing urination but not typically penetrative intercourse. Metoidioplasty has a significantly lower complication rate, shorter operative time (2–4 hours vs 8–14 hours), and faster recovery.
RFF phalloplasty with urethral lengthening in a single stage typically takes 8–14 hours under general anaesthesia. When performed in 2–4 stages, each stage takes 4–8 hours. Penile prosthesis implantation adds a further 1.5–2 hour procedure approximately 12–18 months later. Full functional recovery across all stages takes 18–24 months. Patients should expect 7–14 days in hospital per major stage.
Penile prosthesis implantation is typically planned 12–18 months after phalloplasty, once the neophallus has established a stable blood supply, sensation has partially returned, and all urethral complications have been resolved. Your surgeon will confirm readiness with clinical assessment and imaging of the neophallus vasculature before scheduling the implant procedure.
Urethral fistula (urine leaking through the skin before reaching the meatus) occurs in 15–40% of phalloplasty cases and is the most common complication. Most fistulae close with conservative catheter management; persistent cases require secondary surgical repair. Urethral stricture occurs in 10–25% and is treated by urethroscopic procedures or open urethroplasty. Choosing a high-volume specialist centre significantly reduces these rates compared to lower-volume providers.
In the UK, gender-affirming phalloplasty is available through NHS Gender Identity Clinics, though waiting times commonly exceed 3–5 years. In the US, coverage varies by insurer and state but is increasingly mandated under non-discrimination provisions. Post-cancer and post-trauma reconstruction is generally covered as a medical necessity under most public health systems. Patients should obtain written pre-authorisation and, if denied, appeal with supporting clinical documentation from their surgical team.

References

  1. Rashid M, Tamimy MS. Phalloplasty: the dream and the reality. Indian J Plast Surg. 2013;46(2):283-293.
  2. Coleman E, et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. Int J Transgend Health. 2022;23(S1):S1-S259.
  3. Monstrey S, et al. Penile reconstruction: is the radial forearm flap really the standard technique? Plast Reconstr Surg. 2009;124(2):510-518.
  4. Lumen N, et al. Outcome of urethral reconstruction in gender reassignment surgery. Urology. 2008;71(2):307-311.
  5. Falcone M, et al. Penile prosthesis implantation after gender reassignment surgery: a systematic review. Andrology. 2018;6(6):810-815.
Ad — after-content

Medically Reviewed

Our medical content follows strict editorial guidelines to ensure accuracy and reliability.

Up to Date

Last updated: 2026-07-07

Important: This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.

Ready to take the next step?

Connect with top hospitals and specialists. Get personalized guidance for your medical journey.

Latest from our blog and forum

Latest from Our Blog

View All →

Latest Forum Discussions

View All →
Compare Costs Get Free Help

Medical Disclaimer: The information on MyMedicPlus is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site.